Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
Genentech, Inc.
Canadian Cancer Trials Group
Hanmi Pharmaceutical Company Limited
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute
American Society of Clinical Oncology
University of Utah
Genentech, Inc.
City of Hope Medical Center
Hoffmann-La Roche
InxMed (Shanghai) Co., Ltd.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hoffmann-La Roche
Hoffmann-La Roche
OHSU Knight Cancer Institute
Cancer Research UK
Cancer Research UK
Hoffmann-La Roche
Bristol-Myers Squibb
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
Baylor College of Medicine
City of Hope Medical Center
Rigshospitalet, Denmark
Hoffmann-La Roche
M.D. Anderson Cancer Center
University Hospital, Essen
Fondazione Melanoma Onlus
Alliance for Clinical Trials in Oncology
University Health Network, Toronto
Multiple Myeloma Research Consortium
German Cancer Research Center
Bristol-Myers Squibb
Columbia University
Uppsala University Hospital
Genentech, Inc.
Dana-Farber Cancer Institute
Helsinki University Central Hospital
Queen Mary University of London
ABM Therapeutics Corporation
Hoffmann-La Roche
National Cancer Institute (NCI)
OHSU Knight Cancer Institute
ImmVira Pharma Co. Ltd
OHSU Knight Cancer Institute
Fondazione per la Medicina Personalizzata
Technische Universität Dresden